| Year |
Citation |
Score |
| 2020 |
Bardgett ME, Downnen T, Crane C, Baltes Thompson EC, Muncie B, Steffen SA, Yates JR, Pauly JR. Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference. Neuropharmacology. 108276. PMID 32814089 DOI: 10.1016/J.Neuropharm.2020.108276 |
0.316 |
|
| 2020 |
Bardgett M, Thompson EB. Effects of Early-Life Aripiprazole and Risperidone on Locomotor Activity in Adult Rats Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.721 |
0.318 |
|
| 2017 |
Lee Stubbeman B, Brown CJ, Yates JR, Bardgett ME. Early-life risperidone enhances locomotor responses to amphetamine during adulthood. European Journal of Pharmacology. PMID 28716726 DOI: 10.1016/J.Ejphar.2017.07.025 |
0.302 |
|
| 2013 |
Bardgett ME, Franks-Henry JM, Colemire KR, Juneau KR, Stevens RM, Marczinski CA, Griffith MS. Adult rats treated with risperidone during development are hyperactive. Experimental and Clinical Psychopharmacology. 21: 259-67. PMID 23750695 DOI: 10.1037/a0031972 |
0.327 |
|
| 2012 |
Gannon M, Stevens R, Griffith M, Bardgett M. The effects of early-life risperidone administration on forebrain neurotrophin expression during adulthood Bmc Bioinformatics. 13: 1-1. DOI: 10.1186/1471-2105-13-S12-A19 |
0.3 |
|
| 2010 |
Bardgett ME, Points M, Kleier J, Blankenship M, Griffith MS. The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats. Neuropharmacology. 59: 492-502. PMID 20621107 DOI: 10.1016/j.neuropharm.2010.07.004 |
0.316 |
|
| 2007 |
Bardgett ME, Schultheis PJ, Muzny A, Riddle MD, Wagge JR. Magnesium deficiency reduces fear-induced conditional lick suppression in mice. Magnesium Research : Official Organ of the International Society For the Development of Research On Magnesium. 20: 58-65. PMID 17536490 DOI: 10.1684/mrh.2007.0088 |
0.72 |
|
| 2006 |
Bardgett ME, Baum KT, O'Connell SM, Lee NM, Hon JC. Effects of risperidone on locomotor activity and spatial memory in rats with hippocampal damage. Neuropharmacology. 51: 1156-62. PMID 16934300 DOI: 10.1016/J.Neuropharm.2006.07.014 |
0.325 |
|
| 2006 |
Bardgett ME, Griffith MS, Foltz RF, Hopkins JA, Massie CM, O'Connell SM. The effects of clozapine on delayed spatial alternation deficits in rats with hippocampal damage. Neurobiology of Learning and Memory. 85: 86-94. PMID 16213757 DOI: 10.1016/j.nlm.2005.08.010 |
0.315 |
|
| 2005 |
Bardgett ME, Schultheis PJ, McGill DL, Richmond RE, Wagge JR. Magnesium deficiency impairs fear conditioning in mice. Brain Research. 1038: 100-6. PMID 15748878 DOI: 10.1016/j.brainres.2005.01.020 |
0.731 |
|
| 2003 |
Bardgett ME, Boeckman R, Krochmal D, Fernando H, Ahrens R, Csernansky JG. NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice. Brain Research Bulletin. 60: 131-42. PMID 12725901 DOI: 10.1016/S0361-9230(03)00023-6 |
0.499 |
|
| 2002 |
Bardgett ME, Humphrey WM, Csernansky JG. The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 930-8. PMID 12464450 DOI: 10.1016/S0893-133X(02)00376-7 |
0.538 |
|
| 2002 |
Yin H, Bardgett ME, Csernansky JG. Kainic acid lesions disrupt fear-mediated memory processing. Neurobiology of Learning and Memory. 77: 389-401. PMID 11991765 DOI: 10.1006/Nlme.2001.4037 |
0.479 |
|
| 2002 |
Csernansky JG, Bardgett ME, Dong H, Humphrey W, Wang L. Hippocampal structure and the action of cholinomimetic drugs Drug Development Research. 56: 531-540. DOI: 10.1002/Ddr.10106 |
0.463 |
|
| 2001 |
Humphrey WM, Bardgett ME, Montgomery EM, Taylor GT, Csernansky JG. Methods for inducing neuronal loss in preweanling rats using intracerebroventricular infusion of kainic acid. Brain Research. Brain Research Protocols. 7: 1-10. PMID 11275518 DOI: 10.1016/S1385-299X(00)00055-6 |
0.635 |
|
| 1999 |
Taylor G, Bardgett M, Csernansky J, Early T, Haller J, Scherrer J, Womack S. Neuroleptic influences on a lateralized behavioral bias in unoperated rats Psychopharmacology. 144: 30-37. PMID 10379621 DOI: 10.1007/S002130050973 |
0.693 |
|
| 1999 |
Montgomery EM, Bardgett ME, Lall B, Csernansky CA, Csernansky JG. Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Research. Developmental Brain Research. 112: 107-16. PMID 9974164 DOI: 10.1016/S0165-3806(98)00161-8 |
0.486 |
|
| 1999 |
Faustman WO, Bardgett M, Faull KF, Pfefferbaum A, Csernansky JG. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. Biological Psychiatry. 45: 68-75. PMID 9894577 DOI: 10.1016/S0006-3223(98)00207-8 |
0.511 |
|
| 1998 |
Csernansky JG, Csernansky CA, Kogelman L, Montgomery EM, Bardgett ME. Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biological Psychiatry. 44: 1143-50. PMID 9836017 DOI: 10.1016/S0006-3223(98)00019-5 |
0.491 |
|
| 1998 |
Roe DL, Bardgett ME, Csernansky CA, Csernansky JG. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss. Psychopharmacology. 138: 151-8. PMID 9718284 DOI: 10.1007/S002130050657 |
0.51 |
|
| 1998 |
Newcomer JW, Craft S, Askins K, Hershey T, Bardgett ME, Csernansky JG, Gagliardi AE, Vogler G. Glucocorticoid interactions with memory function in schizophrenia. Psychoneuroendocrinology. 23: 65-72. PMID 9618753 DOI: 10.1016/S0306-4530(97)00081-4 |
0.469 |
|
| 1998 |
Csernansky JG, Bardgett ME. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophrenia Bulletin. 24: 231-48. PMID 9613623 DOI: 10.1093/Oxfordjournals.Schbul.A033323 |
0.468 |
|
| 1998 |
Bardgett ME, Jackson JL, Taylor BM, Csernansky JG. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology. 135: 270-8. PMID 9498730 DOI: 10.1007/S002130050509 |
0.539 |
|
| 1998 |
Sheline YI, Miller K, Bardgett ME, Csernansky JG. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type: Relationship with cognitive dysfunction American Journal of Geriatric Psychiatry. 6: 155-161. DOI: 10.1097/00019442-199805000-00009 |
0.357 |
|
| 1997 |
Bardgett ME, Salaris SL, Jackson JL, Harding J, Csernansky JG. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Psychopharmacology. 133: 142-51. PMID 9342780 DOI: 10.1007/S002130050384 |
0.495 |
|
| 1997 |
Bardgett ME, Jacobs PS, Jackson JL, Csernansky JG. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801. Behavioural Brain Research. 84: 47-55. PMID 9079771 DOI: 10.1016/S0166-4328(96)00132-5 |
0.529 |
|
| 1997 |
Sheline Y, Bardgett ME, Csernansky JG. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology. 17: 11-4. PMID 9004051 DOI: 10.1097/00004714-199702000-00003 |
0.437 |
|
| 1997 |
Montgomery EE, Bardgett ME, Csernansky JG. Limbic-cortical neuropathology in rats: A developmental study Schizophrenia Research. 24: 28. DOI: 10.1016/S0920-9964(97)82080-4 |
0.444 |
|
| 1996 |
Bardgett ME, Newcomer JW, Taylor GT. The effects of chronic corticosterone on memory performance in the platform maze task. Physiology & Behavior. 59: 1111-5. PMID 8737900 DOI: 10.1016/0031-9384(95)02172-8 |
0.579 |
|
| 1996 |
Taylor G, Bardgett M, Csernansky J, Early T, Haller J, Scherrer J, Womack S. Male reproductive systems under chronic fluoxetine or trimipramine treatment. Physiology & Behavior. 59: 479-85. PMID 8700950 DOI: 10.1016/0031-9384(95)02088-8 |
0.678 |
|
| 1996 |
Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology. 46: 1715-20. PMID 8649576 DOI: 10.1212/Wnl.46.6.1715 |
0.412 |
|
| 1996 |
Taylor G, Bardgett M, Farr S, Humphrey W, Womack S, Weiss J. Aging of the Brain-Testicular Axis: Reproductive Systems of Healthy Old Male Rats with or without Endocrine Stimulation Experimental Biology and Medicine. 211: 69-75. PMID 8594620 DOI: 10.3181/00379727-211-43953 |
0.597 |
|
| 1996 |
Bardgett M, Csernansky J. Neurodegeneration in schizophrenia: A possible animal model? Biological Psychiatry. 39: 611-612. DOI: 10.1016/0006-3223(96)84322-8 |
0.42 |
|
| 1996 |
Bardgett ME, Csernansky JG. Antipsychotic Drug Action After Lesions to the Hippocampus or Frontal Cortex Handbook of Experimental Pharmacology. 120: 267-288. DOI: 10.1007/978-3-642-61007-3_9 |
0.461 |
|
| 1995 |
Nelson EC, Sheline YI, Bardgett ME, Jackson JL, Csernansky JG. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder. Psychiatry Research. 58: 117-25. PMID 8570763 DOI: 10.1016/0165-1781(95)02695-S |
0.376 |
|
| 1995 |
Bardgett ME, Jackson JL, Taylor GT, Csernansky JG. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behavioural Brain Research. 70: 153-64. PMID 8561906 DOI: 10.1016/0166-4328(95)80005-0 |
0.661 |
|
| 1995 |
Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG. Platelet serotonin markers and depressive symptomatology. Biological Psychiatry. 37: 442-7. PMID 7786957 DOI: 10.1016/0006-3223(94)00160-5 |
0.387 |
|
| 1995 |
Sheline YI, Black KJ, Bardgett ME, Csernansky JG. Platelet binding characteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 12: 315-22. PMID 7576008 DOI: 10.1016/0893-133X(94)00097-J |
0.394 |
|
| 1995 |
Faustman WO, Ringo DL, Lauriello J, Lim KO, Pfefferbaum A, Bardgett ME, Csernansky JG. Effects of seroquel™ (ICI 204636) on platelet serotonin-2 binding in schizophrenia Schizophrenia Research. 15: 149-150. DOI: 10.1016/0920-9964(95)95464-K |
0.401 |
|
| 1995 |
Bardgett ME, Jackson JL, Csernansky JG. Schizophrenia-like hippocampal neuropathy in rats: Changes in accumbens core and shell dopamine after haloperidol treatment Schizophrenia Research. 15: 142-143. DOI: 10.1016/0920-9964(95)95442-C |
0.481 |
|
| 1994 |
Bardgett ME, Taylor GT, Csernansky JG, Newcomer JW, Nock B. Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behavioral and Neural Biology. 61: 186-90. PMID 8204085 DOI: 10.1016/S0163-1047(05)80074-3 |
0.663 |
|
| 1993 |
Taylor GT, Bardgett M, Farr S, Womack S, Komitowski D, Weiss J. Steroidal interactions in the ageing endocrine system: absence of suppression and pathology in reproductive systems of old males from a mixed-sex socially stressful rat colony. The Journal of Endocrinology. 137: 115-22. PMID 8492069 DOI: 10.1677/Joe.0.1370115 |
0.541 |
|
| 1993 |
Bardgett ME, Wrona CT, Newcomer JW, Csernansky JG. Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics. European Journal of Pharmacology. 230: 245-50. PMID 8095021 DOI: 10.1016/0014-2999(93)90557-X |
0.482 |
|
| 1993 |
Csernansky JG, Wrona CT, Bardgett ME, Early TS, Newcomer JW. Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology. 110: 145-51. PMID 7870875 DOI: 10.1007/Bf02246964 |
0.457 |
|
| 1993 |
Newcomer J, Craft S, Askins K, Hershey T, Bardgett M, Csernansky J. Insensitivity to dexamethasone-induced declarative memory deficits in patients with schizophrenia Schizophrenia Research. 9: 245-246. DOI: 10.1016/0920-9964(93)90552-T |
0.486 |
|
| 1993 |
Bardgett M, Wrona C, Newcomer J, Csernansky J. The effects of intracerebroventricular kainic acid administration on forebrain neurochemistry Schizophrenia Research. 9: 146. DOI: 10.1016/0920-9964(93)90253-F |
0.411 |
|
| 1992 |
Bardgett ME, Taylor GT, Farah JM. Systemic NMDA treatment increases plasma ACTH in the neonatal female and male rat. Brain Research. Developmental Brain Research. 68: 289-93. PMID 1327582 DOI: 10.1016/0165-3806(92)90074-7 |
0.581 |
|
| 1990 |
Taylor GT, Bardgett M, Weiss J. Behaviour and physiology of castrated rats with different episodic schedules of testosterone restoration. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 22: 57-9. PMID 2307393 DOI: 10.1055/s-2007-1004851 |
0.551 |
|
| 1989 |
Taylor GT, Bardgett M, Griffin M, Weiss J. Reproductive behavior and physiology of nulliparous female rats after sexual experience. Behavioural Processes. 19: 31-46. PMID 24895900 DOI: 10.1016/0376-6357(89)90029-6 |
0.578 |
|
| Show low-probability matches. |